top of page

Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

May 1, 2025
0 min read

Recent Posts

Form 6-K- Financial and operating results for the first half of 2025

Form 6-K- Financial and operating results for the first half of 2025

Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

FORM 20-F

bottom of page